Dutch Government champions broad and competitive EU Biotech Act 

The Netherlands is positioning itself at the forefront of Europe’s biotech future! In its newly published non-paper on the EU Biotech Act, the Dutch government calls for a broad, competitive, and innovation-driven approach. The position advocates harmonized and flexible regulation, strong financing, and market creation across medical, agricultural, industrial, and environmental biotech, fully aligned with hollandbio’s asks to “boost biotech broadly, invest in frontrunners, pave the way to market, and remove barriers for uptake.” Besides broad, strategic suggestions, the non-paper proposes targeted action on key focus areas, including clinical trials, biological pest control, GMOs, novel foods, and animal-free methods. Among others, strengthening of knowledge transfer, state aid reform and regulatory sandboxes are highlighted as essential for a thriving biotech ecosystem. With this message, the Dutch government joins hollandbio in urging the EU to seize this moment for bold, integrated action, making Europe the world’s most attractive region for biotech innovation and ensuring smart solutions can deliver for our health, future, and economic growth.